These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nonalcoholic fatty liver disease in patients with different baseline glucose status undergoing bariatric surgery: analysis of intraoperative liver biopsies and literature review. Souto KP; Meinhardt NG; Ramos MJ; Ulbrich-Kulkzynski JM; Stein AT; Damin DC Surg Obes Relat Dis; 2018 Jan; 14(1):66-73. PubMed ID: 29104004 [TBL] [Abstract][Full Text] [Related]
5. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701 [TBL] [Abstract][Full Text] [Related]
6. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial. Praveen Raj P; Gomes RM; Kumar S; Senthilnathan P; Karthikeyan P; Shankar A; Palanivelu C Surg Obes Relat Dis; 2015; 11(6):1315-22. PubMed ID: 26003897 [TBL] [Abstract][Full Text] [Related]
7. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863 [TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation. Cazzo E; de Felice Gallo F; Pareja JC; Chaim EA Obes Surg; 2014 Apr; 24(4):666-8. PubMed ID: 24415281 [TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Weiner RA Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923 [TBL] [Abstract][Full Text] [Related]
10. Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study. Seeberg KA; Hofsø D; Borgeraas H; Grimnes JO; Fatima F; Seeberg LT; Kvan NP; Svanevik M; Hertel JK; Hjelmesæth J BMC Gastroenterol; 2022 Nov; 22(1):448. PubMed ID: 36336684 [TBL] [Abstract][Full Text] [Related]
11. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Aller de la Fuente R; Mora Cuadrado N; Tafur C; López Gómez JJ; Gómez de la Cuesta S; García Sánchez MC; Antolin Melero B; de Luis Román DA Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):354-360. PubMed ID: 29477355 [TBL] [Abstract][Full Text] [Related]
12. Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. Tai CM; Huang CK; Hwang JC; Chiang H; Chang CY; Lee CT; Yu ML; Lin JT Obes Surg; 2012 Jul; 22(7):1016-21. PubMed ID: 22161114 [TBL] [Abstract][Full Text] [Related]
13. Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study. Mantovani A; Zusi C; Csermely A; Salvagno GL; Colecchia A; Lippi G; Maffeis C; Targher G Hormones (Athens); 2022 Sep; 21(3):477-486. PubMed ID: 35831700 [TBL] [Abstract][Full Text] [Related]
14. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684 [TBL] [Abstract][Full Text] [Related]
15. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Larson SP; Bowers SP; Palekar NA; Ward JA; Pulcini JP; Harrison SA Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Schindler K; Würger T; Wrba F; Trauner M; Prager G; Ludvik B Obes Surg; 2016 Oct; 26(10):2425-32. PubMed ID: 26989059 [TBL] [Abstract][Full Text] [Related]
18. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Cazzo E; Jimenez LS; Pareja JC; Chaim EA Obes Surg; 2015 Jun; 25(6):982-5. PubMed ID: 25381118 [TBL] [Abstract][Full Text] [Related]
19. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus. Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708 [TBL] [Abstract][Full Text] [Related]